Clinical trial
Glucosidase Inhibitors and Glucose Metabolism
NCT07254624 is registered in ClinicalTrials.gov with University of Alabama at Birmingham as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Glucosidase Inhibitors and Glucose Metabolism
- Lead sponsor
- University of Alabama at Birmingham
- Phase
- Not applicable
- Overall status
- Active, not recruiting
- Start date
- March 16, 2026
- Completion date
- November 30, 2027
- Enrollment
- 10 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
post-prandial glucose response